178例骨科Ⅰ类切口手术围术期抗菌药物应用分析
|
摘要
目的了解药学干预前后对骨科Ⅰ类切口手术围术期抗菌药物应用合理性的影响。方法对2018年第一季度和第三季度某院骨科Ⅰ类切口手术围术期抗菌药物的应用情况进行回顾性分析,对比分析围术期应用抗菌药物的合理情况。结果抗菌药物预防性使用率、术后用药疗程不合理率,分别由药学干预前74.12%、36.51%下降为药学干预后54.84%、9.8%,并且抗菌药物种类选择、给药时间更为合理。结论经过药学干预,骨科Ⅰ类切口手术围术期抗菌药物的不合理情况有不同程度的改善。
Objective To investigate the intervention on perioperative use of antibacterials in patients undergoing type Ⅰ incision operation. Methods The perioperative use of antibacterials in a total of 178 patients undergoing orthopedic surgery in our hospital from the first and the third quarter of 2018.The preventive application of antibacterials in type Ⅰ incision were analyzed.Results The rate of prophylactic use and postoperative course of medication decreased respectively from 74.12%、36.51% of the first quarter to 54.84%、9.8% of the third quarter respectively. Conclusion Clinicalpharmaceutical care and intervention contributed to improvement of the irrational use of drugs in type Ⅰ incision operation.
Objective To investigate the intervention on perioperative use of antibacterials in patients undergoing type Ⅰ incision operation. Methods The perioperative use of antibacterials in a total of 178 patients undergoing orthopedic surgery in our hospital from the first and the third quarter of 2018.The preventive application of antibacterials in type Ⅰ incision were analyzed.Results The rate of prophylactic use and postoperative course of medication decreased respectively from 74.12%、36.51% of the first quarter to 54.84%、9.8% of the third quarter respectively. Conclusion Clinicalpharmaceutical care and intervention contributed to improvement of the irrational use of drugs in type Ⅰ incision operation.
引文
[1]卫计委办公室,国家中医药管理局办公室,总后卫生部药品器材局.关于印发《抗菌药物临床应用指导原则(2015年版)》的通知[S].国卫办医发[2015]43号.2015-07-24.
[2]卫生部办公厅.关于做好全国抗菌药物临床应用专项整治活动的通知[S].卫办医政发[2011]56号.
[3]卫生部办公厅.关于继续深入开展全国抗菌药物临床应用专项整治活动的通知[S].卫办医政发[2012]32号.
[4]钟松阳,刘伟.95例Ⅰ类手术切口围手术期预防性使用抗菌药物调查分析[J].中华医院感染学杂志,2011,21(18):3926-3928.
[5]赵巍,霍建忠.骨科围手术期感染与抗菌药物的应用策略[J].山西医药杂志,2014,43(10):1141-1143.
[6]李家田.207例Ⅰ类切口手术预防用药调查分析[J].安徽医药,2012,16(8):1177-1178.
[7]洪海军.息县人民医院妇产科手术患者围术期预防性应用抗菌药物分析[J].中国医院用药评价与分析,2013,13(5):430-434.
[8]于卫江,张文周,张斌,等.我院Ⅰ类切口围术期抗菌药物预防应用干预性研究[J].中国药房,2014,25(10):870-872.
[9]王芳,包蕾,曹亚丽.骨科Ⅰ类切口手术预防性使用抗菌药物调查分析[J].中华医院感染学杂志,2012,22(21):4867-4869.
[10]张士洋,程军,叶云,等.PDCA循环规范骨科围术期抗菌药物预防使用的研究[J].中国药物警戒,2013,10(11):690-692,695.
[11]王景红,黄毅岚,罗宏丽.某地区8所医院1570例患者围手术期抗菌药物预防性应用分析[J].中华医院感染学杂志,2012,22(13):2891-2893.
[12]赵瑛,徐宁路.1271例骨科Ⅰ类切口手术围术期预防性应用抗菌药物分析[J].中国医院用药评价与分析,2016,16(9):1264-1266.
[13]Salkind AR,Rao KC.Antiobiotic prophylaxis to prevent surgical site infections[J].Am Fam Physician,2011,83(5):585-590.
[2]卫生部办公厅.关于做好全国抗菌药物临床应用专项整治活动的通知[S].卫办医政发[2011]56号.
[3]卫生部办公厅.关于继续深入开展全国抗菌药物临床应用专项整治活动的通知[S].卫办医政发[2012]32号.
[4]钟松阳,刘伟.95例Ⅰ类手术切口围手术期预防性使用抗菌药物调查分析[J].中华医院感染学杂志,2011,21(18):3926-3928.
[5]赵巍,霍建忠.骨科围手术期感染与抗菌药物的应用策略[J].山西医药杂志,2014,43(10):1141-1143.
[6]李家田.207例Ⅰ类切口手术预防用药调查分析[J].安徽医药,2012,16(8):1177-1178.
[7]洪海军.息县人民医院妇产科手术患者围术期预防性应用抗菌药物分析[J].中国医院用药评价与分析,2013,13(5):430-434.
[8]于卫江,张文周,张斌,等.我院Ⅰ类切口围术期抗菌药物预防应用干预性研究[J].中国药房,2014,25(10):870-872.
[9]王芳,包蕾,曹亚丽.骨科Ⅰ类切口手术预防性使用抗菌药物调查分析[J].中华医院感染学杂志,2012,22(21):4867-4869.
[10]张士洋,程军,叶云,等.PDCA循环规范骨科围术期抗菌药物预防使用的研究[J].中国药物警戒,2013,10(11):690-692,695.
[11]王景红,黄毅岚,罗宏丽.某地区8所医院1570例患者围手术期抗菌药物预防性应用分析[J].中华医院感染学杂志,2012,22(13):2891-2893.
[12]赵瑛,徐宁路.1271例骨科Ⅰ类切口手术围术期预防性应用抗菌药物分析[J].中国医院用药评价与分析,2016,16(9):1264-1266.
[13]Salkind AR,Rao KC.Antiobiotic prophylaxis to prevent surgical site infections[J].Am Fam Physician,2011,83(5):585-590.